MILLENNIUM MANAGEMENT LLC - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 134 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2017. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$75,000
-90.9%
379,382
-79.2%
0.00%
-100.0%
Q3 2018$824,000
-24.9%
1,827,248
-16.1%
0.00%0.0%
Q2 2018$1,097,000
-78.2%
2,177,950
+1.1%
0.00%
-85.7%
Q1 2018$5,021,000
-21.1%
2,154,884
-3.9%
0.01%
-22.2%
Q4 2017$6,366,000
+20.9%
2,241,521
+21.8%
0.01%
+12.5%
Q3 2017$5,264,000
+1278.0%
1,840,556
+1089.1%
0.01%
+700.0%
Q2 2017$382,000
+54.7%
154,781
+126.6%
0.00%
Q1 2017$247,000
-92.9%
68,310
-93.1%
0.00%
-100.0%
Q4 2016$3,487,000
+25.6%
985,104
+43.4%
0.01%
+40.0%
Q3 2016$2,776,000
+188.9%
687,055
+213.9%
0.01%
+150.0%
Q2 2016$961,000
-90.0%
218,907
-91.4%
0.00%
-91.7%
Q1 2016$9,641,000
+98.7%
2,550,547
+724.4%
0.02%
+140.0%
Q4 2015$4,851,000
-39.8%
309,399
-59.5%
0.01%
-37.5%
Q3 2015$8,056,000
-42.3%
764,343
+38.1%
0.02%
-38.5%
Q2 2015$13,959,000
-75.8%
553,473
-73.3%
0.03%
-75.7%
Q1 2015$57,704,000
+3940.9%
2,070,467
+2545.5%
0.11%
+3466.7%
Q4 2014$1,428,000
+920.0%
78,264
+624.7%
0.00%
Q3 2014$140,000
-97.7%
10,800
-96.8%
0.00%
-100.0%
Q1 2014$6,039,000
+74.7%
341,800
+139.4%
0.02%
+54.5%
Q4 2013$3,457,000
-54.9%
142,800
-34.0%
0.01%
-56.0%
Q3 2013$7,664,000
+108.7%
216,302
-8.1%
0.02%
+127.3%
Q2 2013$3,672,000235,2530.01%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q4 2017
NameSharesValueWeighting ↓
TSP Capital Management Group, LLC 813,273$3,286,0001.66%
RTW INVESTMENTS, LP 1,243,164$5,022,0001.52%
Marcus Capital, LLC 112,200$453,0000.44%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 996,178$4,024,0000.29%
Benchmark Capital Advisors 67,000$271,0000.20%
SUFFOLK CAPITAL MANAGEMENT LLC 360,299$1,456,0000.20%
COLUMBIA WANGER ASSET MANAGEMENT LLC 2,907,523$11,746,0000.15%
Virtus ETF Advisers LLC 59,537$241,0000.12%
Bellevue Group AG 160,000$646,0000.12%
PDT Partners, LLC 428,300$1,730,0000.10%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders